1. The diagnostic efficacy of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in ovarian cancer
   Anastasia Prodromidou et al, 2017, Inflamm. Res. CrossRef
2. Retrospective evaluation of ultrasound-indeterminate renal multilocular cystic masses by using neutrophil-lymphocyte ratio and computed tomography
   Hanfeng Wang et al, 2017, Urologic Oncology: Seminars and Original Investigations CrossRef
3. A nomogram based on preoperative inflammatory markers predicting the overall survival of pancreatic ductal adenocarcinoma
   Jie Xu et al, 2017, Journal of Gastroenterology and Hepatology CrossRef
4. The platelet-to-lymphocyte ratio as a predictor of patient outcomes in ovarian cancer: a meta-analysis
   X-M. Ma et al, 2017, Climacteric CrossRef
5. Glioblastoma-synthesized G-CSF and GM-CSF contribute to growth and immunosuppression: Potential therapeutic benefit from dapsone, fenofibrate, and ribavirin
   Richard E Kast et al, 2017, Tumour Biol. CrossRef
6. Is There Any Difference in Platelets Indices Between Benign and Malignant Epithelial Tumors of the Ovary?
   Setare Nassiri et al, 2017, Indian J Gynecol Oncolog CrossRef
7. Pretreatment neutrophil-to-lymphocyte ratio and its dynamic change during neoadjuvant chemotherapy as poor prognostic factors in advanced ovarian cancer
   Yun-Ji Kim et al, 2018, Obstet Gynecol Sci CrossRef
8. Analysis of preoperative blood platelet parameters in terms of diversity of epithelial ovarian cancer
   Katarzyna Bednarska et al, 2018, Medicine CrossRef
9. The Predictive Value of Inflammation-Related Peripheral Blood Measurements in Cancer Staging and Prognosis
   Joanna L. Sylman et al, 2018, Front. Oncol. CrossRef
10. Neutrophil to lymphocyte and platelet to lymphocyte ratios increase in ovarian tumors in the presence of frank stromal invasion
    M. Polat et al, 2016, Clin Transl Oncol CrossRef
11. Heterogeneity of the Mac-1 expression on peripheral blood neutrophils in patients with different types of epithelial ovarian cancer
    Katarzyna Bednarska et al, 2016, Immunobiology CrossRef
12. Does preoperative neutrophil to lymphocyte or platelet to lymphocyte ratios have a role in predicting borderline ovarian tumors?
    Ghanim Khatib et al, 2016, J Ovarian Res CrossRef
13. Diagnostic value of serum D‐dimer, CA 125, and neutrophil‐to‐lymphocyte ratio in differentiating ovarian cancer and endometriosis
    Lifeng Chen et al, 2019, Int J Gynecol Obstet CrossRef
14. Predictive value of systematic inflammatory response biomarkers (NLR, LMR, PLR) in patients with ovarian cancer.
    Urszula Rychlik et al, 2017, diagn lab CrossRef
15. Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy
    M. Liontos et al, 2021, J Ovarian Res CrossRef
16. Evaluation of Combined Cancer Markers With Lactate Dehydrogenase and Application of Machine Learning Algorithms for Differentiating Benign Disease From Malignant Ovarian Cancer
    Seri Jeong et al, 2021, Cancer Control CrossRef
17. Neutrophil–Lymphocyte and Platelet–Lymphocyte Ratios in Preoperative Differential Diagnosis of Benign, Borderline, and Malignant Ovarian Tumors
    Tae Hui Yun et al, 2022, JCM CrossRef
18. Comparative analysis of haematological, biochemical and nutritional parameters of Dezhou donkey with healthy and weak foals (Equus asinus)
    Yuanxi Yue et al, 2022, Italian Journal of Animal Science CrossRef
19. Independent predictive value of blood inflammatory composite markers in ovarian cancer: recent clinical evidence and perspective focusing on NLR and PLR
    Chuan-long Zhang et al, 2023, J Ovarian Res CrossRef
20. Crosstalk of Immune Cells and Platelets in an Ovarian Cancer Microenvironment and Their Prognostic Significance
    Katarzyna Aneta Pankowska et al, 2023, IJMS CrossRef
21. Comparison of the diagnostic efficacy of systemic inflammatory indicators in the early diagnosis of ovarian cancer
    Liyun Song et al, 2024, Front. Oncol. CrossRef